These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7497137)

  • 21. Body mass index and breast cancer survival in relation to the introduction of mammographic screening.
    Olsson A; Garne JP; Tengrup I; Zackrisson S; Manjer J
    Eur J Surg Oncol; 2009 Dec; 35(12):1261-7. PubMed ID: 19481409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
    Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
    Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.
    Frisell J; Lidbrink E; Hellström L; Rutqvist LE
    Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update of the Swedish two-county program of mammographic screening for breast cancer.
    Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
    Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
    Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
    Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
    Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated mammographic screening reduces breast cancer mortality along the continuum of age.
    Broeders MJ; Verbeek AL; Straatman H; Peer PG; Jong PC; Beex LV; Hendriks JH; Holland R
    J Med Screen; 2002; 9(4):163-7. PubMed ID: 12518006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years.
    Thurfjell EL; Lindgren JA
    Radiology; 1996 Nov; 201(2):421-6. PubMed ID: 8888234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
    Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammography screening matters for young women with breast carcinoma: evidence of downstaging among 42-49-year-old women with a history of previous mammography screening.
    Buseman S; Mouchawar J; Calonge N; Byers T
    Cancer; 2003 Jan; 97(2):352-8. PubMed ID: 12518359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
    Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
    J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years.
    Frisell J; Lidbrink E
    J Natl Cancer Inst Monogr; 1997; (22):49-51. PubMed ID: 9709275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.
    Chiu SY; Duffy S; Yen AM; Tabár L; Smith RA; Chen HH
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1219-28. PubMed ID: 20406961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial.
    Tabár L; Faberberg G; Day NE; Holmberg L
    Br J Cancer; 1987 May; 55(5):547-51. PubMed ID: 3606947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts.
    Nystrom L; Larsson LG; Wall S; Rutqvist LE; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabar L
    J Med Screen; 1996; 3(2):85-7. PubMed ID: 8849766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.